A comparison of the safety and efficacy of brimonidine 0.2% bid versus tid, in subjects with elevated intraocular pressure

被引：0

作者：

Rosenthal, AL ^{[1
]}

Walters, T ^{[1
]}

Berg, E ^{[1
]}

Safyan, E ^{[1
]}

Batoosingh, AL ^{[1
]}

机构：

[1] ALLERGAN PHARMACEUT INC,OPHTHALMOL CLIN RES,IRVINE,CA

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 1996年 / 37卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：5071 / 5071

页数：1

共 50 条

[41] Dorzolamide/timolol fixed combination versus concomitant administration of brimonidine and timolol in patients with elevated intraocular pressure - A 3-month comparison of efficacy, tolerability, and patient-reported measures
Solish, AM
DeLucca, PT
Cassel, DA
Kolodny, AH
Hustad, CM
Skobieranda, F
JOURNAL OF GLAUCOMA, 2004, 13 (02) : 149 - 157
[42] Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure
Lee, Anne J.
McCluskey, Peter
CLINICAL OPHTHALMOLOGY, 2008, 2 (03): : 545 - 555
[43] Latanoprost or brimonidine as treatment for elevated intraocular pressure - Multicenter trial in the United States
Camras, CB
Sheu, RP
JOURNAL OF GLAUCOMA, 2005, 14 (02) : 161 - 167
[44] Efficacy and safety of fixed-dose combination brinzolamide 1%/brimonidine 0.2% as adjunctive therapy to prostaglandin analogs in patients with elevated intraocular pressure: Results from pooled analysis of two multicenter, randomized studies
Hubatsch, Doug
Realini, Tony
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
[45] Comparative study of apraclonidine 0.5% versus brimonidine 0.2% in post-argon laser trabeculoplasty intraocular pressure spike prophylaxis
Hughes, BA
Basse, L
Kim, C
Shin, DH
Eliassi-Rad, B
Nootheti, P
Chung, HS
Birt, C
Reed, SY
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S753 - S753
[46] Effectiveness and safety of brimonidine as adjunctive therapy for patients with elevated intraocular pressure in a large, open-label community trial
Lee, DA
Gornbein, JA
JOURNAL OF GLAUCOMA, 2001, 10 (03) : 220 - 226
[47] Efficacy and safety of combination therapy with brimonidine 0.2% and latanoprost 0.005% versus fixed combination timolol 0.5%/dorzolamide 2%.
Zabriskie, NA
Ahmed, IK
Cantor, LB
Kent, AB
Mundorf, T
Tauber, J
Rubin, JM
Hoop, J
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S833 - S833
[48] Comparison of intraocular pressure in glaucoma subjects treated with Xalatan® versus generic latanoprost
Egan, Patrick
Harris, Alon
Siesky, Brent
Abrams-Tobe, Leslie
Gerber, Austin L.
Park, Joshua
Holland, Steven
Kim, Nathaniel J.
Januleviciene, Ingrida
ACTA OPHTHALMOLOGICA, 2014, 92 (05) : E415 - E416
[49] A comparison of the short-term hypotensive effects and side effects of unilateral brimonidine and apraclonidine in patients with elevated intraocular pressure
Yüksel, NE
Karabas, L
Altintas, Ö
Yildirim, Y
Çaglar, Y
OPHTHALMOLOGICA, 2002, 216 (01) : 45 - 49
[50] ONE DROP STUDY TO EVALUATE SAFETY AND EFFICACY OF AN OPHTHALMIC CALCIUM-CHANNEL BLOCKER, VERAPAMIL, IN SUBJECTS WITH ELEVATED INTRAOCULAR-PRESSURE
MOOSHIAN, ML
LEONARDI, LM
SCHOOLEY, GL
ERICKSON, K
GREINER, JV
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1993, 34 (04) : 924 - 924

← 1 2 3 4 5 →